CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-05 | Flammer Martina M.D. Chief Medical Officer | Sale | −1,386 | $29.21 | $40K | 117,525 |
| 2024-01-05 | Adsett Roger Chief Operating Officer | Sale | −3,042 | $29.21 | $89K | 161,183 |
| 2024-01-04 | Wise John Drayton Chief Commercial Officer | Grant or award 10b5-1 | +12,873 | 116,857 | ||
| 2024-01-04 | Wise John Drayton Chief Commercial Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +63,560 | 63,560 | ||
| 2024-01-04 | Smith Michael Alexander General Counsel, Senior VP | Grant or award | +11,800 | 89,364 | ||
| 2024-01-04 | Smith Michael Alexander General Counsel, Senior VP | Grant or award · Stock Option (right to buy) | +58,260 | 58,260 | ||
| 2024-01-04 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award | +11,800 | 106,606 | ||
| 2024-01-04 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award · Stock Option (right to buy) | +58,260 | 58,260 | ||
| 2024-01-04 | Lewis William Chair and CEO | Grant or award | +37,869 | 380,517 | ||
| 2024-01-04 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +186,970 | 186,970 | ||
| 2024-01-04 | Flammer Martina M.D. Chief Medical Officer | Grant or award | +12,873 | 118,911 | ||
| 2024-01-04 | Flammer Martina M.D. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +63,560 | 63,560 | ||
| 2024-01-04 | Bonstein Sara Chief Financial Officer | Grant or award | +12,873 | 118,548 | ||
| 2024-01-04 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +63,560 | 63,560 | ||
| 2024-01-04 | Adsett Roger Chief Operating Officer | Grant or award | +12,873 | 164,225 | ||
| 2024-01-04 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) | +63,560 | 63,560 | ||
| 2024-01-03 | Wise John Drayton Chief Commercial Officer | Exercise or conversion 10b5-1 | +20,071 | $19.11 | $384K | 124,055 |
| 2024-01-03 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −20,071 | $29.19 | $586K | 103,984 |
| 2024-01-03 | Wise John Drayton Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −20,071 | 0 | ||
| 2023-12-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +22,288 | $20.49 | $457K | 116,837 |
Page 44 of 54 · 1,061 trades